✦ LIBER ✦

Activity of the Epipodophyllotoxin VP-16 in the Treatment of Combination Chemotherapy-Resistant Non-Hodgkin Lymphoma

✍ Scribed by Richard A. Bender; Tom Anderson; Richard I. Fisher; Robert C. Young

Publisher: John Wiley and Sons
Year: 1978
Tongue: English
Weight: 397 KB
Volume: 5
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830050305

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thromboembolism. A complication of weekl

Thromboembolism. A complication of weekly chemotherapy in the treatment of non-Hodgkin's lymphoma

✍ C. S. Clarke; B. W. Otridge; D. N. Carney 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

Treatment of non-Hodgkin's lymphoma in t

Treatment of non-Hodgkin's lymphoma in the elderly: an update

✍ Umberto Tirelli; Vittorina Zagonel; Domenico Errante; Lucia Fratino; Silvio Monf 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

Recent studies specifically directed toward assessing the outcome of older patients with non-Hodgkin's lymphoma (NHL) indicate that age per se is an important and independent prognostic factor for response and survival. We report a review of the clinical trials of the literature and the Aviano Group

Results of total body irradiation in the

Results of total body irradiation in the treatment of advanced non-Hodgkin's lymphomas

✍ Steven C. Carabell; John T. Chaffey; David S. Rosenthal; William C. Moloney; Sam 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

Total body irradiation (TBI) was used as primary therapy for 58 previously untreated patients with Stage III or IV non-Hodgkin's lymphoma (NHL). 150 rad was administered, with 15 rad fractions twice a week, with careful monitoring of hematologic status. Thrombocytopenia was the most frequent complic

Second-line chemotherapy in human immuno

Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: Evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients

✍ Umberto Tirelli; Domenico Errante; Michele Spina; Roberta Gastaldi; Ezio Nigra; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 2 views

## BACKGROUND. There is very little experience reported in the literature on the treatment of patients with relapsed or resistant human immunodeficiency virus-related non-Hodgkin's lymphoma (HIV-NIIL). We performed a prospective study to ovaluate the feasibility and activity of a second-line chemo

Oral combination chemotherapy in conjunc

Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: Evaluation of the role of G-CSF; Quality-of-life analysis and long-term follow-up

✍ Scot C. Remick; Nell Sedransk; Richard F. Haase; Christina G. Blanchard; Carm R. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

Cladribine in the treatment of advanced

Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma

✍ Anil Tulpule; Gary Schiller; Laura A. Harvey-Buchanan; Myung Lee; Byron M. Espin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## BACKGROUND. Cladribine (2-chlorodeoxyadenosine) is a purine nucleoside analog with cytotoxic activity against both resting and proliferating cells. Clinical studies with cladribine have reported antitumor activity against various hematologic malignancies.